Dr. Derek Exner, associate dean of commercialization and innovation at the University of Calgary’s Cumming School of Medicine, and his team have been working closely with American medical device company Abbott since 2014. Together, the group has been instrumental in bringing the Aveir leadless pacemaker to patients with heart conditions in Calgary.Sign up to receive daily headline news from the Calgary Herald, a division of Postmedia Network Inc.
Unlike a traditional pacemaker, the Aveir is leadless, which means it doesn’t have wires connecting the device to the patient’s bloodstream and then to the heart. Older models are also bulky, can be bothersome for patients and expend a lot of energy. “Access to this is somewhat limited because of the people who can do it, and people who are trained to do it safely and appropriately,” he said.
I'm sure there'll be some anti-pacemaker narrative, complete with fake 'experts' and 'data' and an army of supposedly true-believers in 3...2...